Titre:
  • Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Auteur:Lismond, Ann; Carbonnelle, Sylviane; Verhaegen, Jan; Schatt, Patricia; De Bel, A; Jordens, Paul; Jacobs, Frédérique; Dediste, Anne; Verschuren, Frank; Huang, Te-Din; Tulkens, Paul M.; Glupczynski, Youri; Van Bambeke, Françoise
Informations sur la publication:International journal of antimicrobial agents, 39, 3, page (208-216)
Statut de publication:Publié, 2012-03
Sujet CREF:Cancérologie
Mots-clés:β-Lactams
Breakpoints
CLSI
Community-acquired pneumonia
EUCAST
Fluoroquinolones
Macrolides
Serotyping
Streptococcus pneumoniae
Vaccine
MeSH keywords:Adolescent
Adult
Aged
Aged, 80 and over
Amoxicillin -- pharmacology
Anti-Bacterial Agents -- pharmacology
Aza Compounds -- pharmacology
Belgium -- epidemiology
Child
Child, Preschool
Clarithromycin -- pharmacology
Community-Acquired Infections -- diagnosis -- drug therapy -- microbiology
Comorbidity
Drug Resistance, Multiple, Bacterial
Humans
Microbial Sensitivity Tests -- standards
Middle Aged
Pneumonia, Pneumococcal -- diagnosis -- drug therapy -- microbiology
Quinolines -- pharmacology
Streptococcus pneumoniae -- drug effects -- isolation & purification -- pathogenicity
Vaccination
Young Adult
beta-Lactams -- pharmacology
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0924-8579
info:doi/10.1016/j.ijantimicag.2011.11.011
info:pii/S0924-8579(11)00469-9
info:scp/84857058767
info:pmid/22245497